| 摘要 |
<p>It is intended to provide a medicinal composition for treating lung cancer and a diagnostic for lung cancer. More specifically speaking, it is intended to provide a medicinal composition for treating lung cancer and a diagnostic for lung cancer containing an antibody capable of binding to the β-chain of an interleukin-20 receptor; and a method of detecting lung cancer which comprises detecting the expression of the β-chain of the interleukin-20 receptor in a sample obtained from a mammal being likely to have lung cancer.</p> |
